This is a preview of subscription content, log in via an institution to check access.
Reference
Winn A, et al. Cost-Effectiveness of FDA-Approved Cancer Drugsince 2000. 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PCN74, 18 May 2013.
Rights and permissions
About this article
Cite this article
A decade of new cancer drugs: good value for money. PharmacoEcon Outcomes News 680, 10 (2013). https://doi.org/10.1007/s40274-013-0476-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0476-5